Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells

被引:110
|
作者
Balakrishnan, Kumudha [1 ]
Wierda, William G. [2 ]
Keating, Michael J. [2 ]
Gandhi, Varsha [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Unit 71, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukaemia, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2007-12-126946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gossypol, a cottonseed extract derivative, acts as a BH3-mimetic, binding to the BH3 pocket of antiapoptotic proteins and displacing pro-death partners to induce apoptosis. However, knowledge on the molecular underpinnings of its downstream effects is limited. Since chronic lymphocytic leukemia (CLL) cells express high levels of antiapoptotic proteins that act as a survival mechanism for these replicationally quiescent lymphocytes, we investigated whether gossypol induces apoptosis in these cells and what mechanism underlies gossypol-mediated cytotoxicity. Gossypol induced cell death in a concentration- and time-dependent manner; 24-hour incubation with 30 mu M gossypol resulted in 50% cell death (median; range, 10%-80%; n = 47) that was not abrogated by pan-specific caspase inhibitor. Starting at 4 hours, the mitochondrial outer membrane was significantly permeabilized (median, 77%; range, 54%-93%; n = 15). Mitochondrial outer membrane permeabiliztalon (MOMP) was concurrent with increased production of reactive oxygen species (ROS); however, antioxidants did not abrogate gossypol-induced cell death. Mitochondrial membrane permeabilization was also associated with loss of intracellular adenosine triphosphate (ATP), activation of BAX, and release of cytochrome c and apoptosis-inducing factor (AIF), which was translocated to the nucleus. Blocking AIF translocation resulted in a decreased apoptosis, suggesting that AIF contributes to gossypol-mediated cytotoxicity in CLL lymphocytes.
引用
收藏
页码:1971 / 1980
页数:10
相关论文
共 50 条
  • [1] BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia
    Anderson, Mary Ann
    Huang, David C. S.
    Roberts, Andrew W.
    LEUKEMIA & LYMPHOMA, 2013, 54 (05) : 909 - 911
  • [2] Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic
    Ghiotto, Fabio
    Fais, Franco
    Tenca, Claudya
    Tomati, Valeria
    Morabito, Fortunato
    Casciaro, Salvatore
    Mumot, Anna
    Zoppoli, Gabriele
    Ciccone, Ermanno
    Parodi, Silvio
    Bruno, Silvia
    CANCER BIOLOGY & THERAPY, 2009, 8 (03) : 263 - 271
  • [3] The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro
    Lisa Haasler
    Arun Kumar Kondadi
    Thanos Tsigaras
    Claudia von Montfort
    Peter Graf
    Wilhelm Stahl
    Peter Brenneisen
    Archives of Toxicology, 2021, 95 : 1349 - 1365
  • [4] The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro
    Haasler, Lisa
    Kondadi, Arun Kumar
    Tsigaras, Thanos
    von Montfort, Claudia
    Graf, Peter
    Stahl, Wilhelm
    Brenneisen, Peter
    ARCHIVES OF TOXICOLOGY, 2021, 95 (04) : 1349 - 1365
  • [5] Bax and Bak are required for apogossypolone, a BH3-mimetic, induced apoptosis in chronic lymphocytic leukemia cells
    Balakrishnan, Kumudha
    Aggarwal, Sumesh
    Wierda, William
    Gandhi, Varsha
    LEUKEMIA & LYMPHOMA, 2013, 54 (05) : 1097 - 1100
  • [6] Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia
    Billard, C.
    LEUKEMIA, 2012, 26 (09) : 2032 - 2038
  • [7] The pro-death role of autophagy and apoptosis in cell death induced by the BH3 mimetic gossypol
    Kim, Na-Yeon
    Lee, Michael
    ANIMAL CELLS AND SYSTEMS, 2014, 18 (03) : 183 - 189
  • [8] Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia
    C Billard
    Leukemia, 2012, 26 : 2032 - 2038
  • [9] In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells
    Oliver, CL
    Bauer, JA
    Wolter, KG
    Ubell, ML
    Narayan, A
    O'Connell, KM
    Fisher, SG
    Wang, SM
    Wu, XH
    Ji, M
    Carey, TE
    Bradford, CR
    CLINICAL CANCER RESEARCH, 2004, 10 (22) : 7757 - 7763
  • [10] The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
    K D Mason
    S L Khaw
    K C Rayeroux
    E Chew
    E F Lee
    W D Fairlie
    A P Grigg
    J F Seymour
    J Szer
    D C S Huang
    A W Roberts
    Leukemia, 2009, 23 : 2034 - 2041